磁共振成像与超声识别不同程度肝脂肪变的效能:系统综述与Meta分析
该Meta分析纳入38项研究、5056例代谢功能障碍相关脂肪性肝病患者,以组织学为参考标准,评估MRI质子密度脂肪分数(MRI-PDFF)、受控衰减参数(CAP)和衰减系数(AC)对肝脂肪变分级的诊断效能。结果显示MRI-PDFF与AC在诊断中重度脂肪变时准确度优于CAP,而MRI-PDFF与AC效能相似;作者建议将AC纳入超声常规筛查。
要点
- MRI-PDFF诊断≥S1、≥S2、≥S3脂肪变的AUC分别为0.99、0.89、0.90。
- AC诊断≥S1、≥S2、≥S3脂肪变的AUC分别为0.97、0.90、0.89,与MRI-PDFF相似。
- CAP诊断≥S2和≥S3脂肪变的AUC低于MRI-PDFF和AC(P<0.001)。
核心结论
- 与CAP直接比较,MRI-PDFF和AC诊断中度和重度脂肪变的准确度更高,且MRI-PDFF与AC诊断效能相似;作者认为对于脂肪变患者,AC应纳入超声常规筛查。
研究设计与样本
- 系统综述与Meta分析,全面检索PubMed、Cochrane Library、Embase和Web of Science数据库至2024年6月,纳入38项研究、5056例代谢功能障碍相关脂肪性肝病患者,以组织学为参考标准,采用双变量随机效应模型计算合并敏感度、特异度和AUC。
诊断标准与关键数值
- MRI-PDFF诊断≥S1、≥S2、≥S3脂肪变的AUC分别为0.99、0.89、0.90;CAP分别为0.95、0.84、0.77;AC分别为0.97、0.90、0.89。CAP诊断≥S2的AUC低于MRI-PDFF(0.89 vs. 0.84,p<0.001)和AC(0.90 vs. 0.84,p<0.001);CAP诊断≥S3的AUC低于MRI-PDFF(0.90 vs. 0.77,p<0.001)和AC(0.89 vs. 0.77,p<0.001)。
临床应用与阅片要点
- 作者认为对于脂肪变患者,AC应纳入超声常规筛查;亚组分析显示,在亚洲人群、体重指数≤30 kg/m2及年龄<51岁者中,MRI-PDFF和CAP诊断≥S2和≥S3脂肪变的效能更优。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: MRI proton density fat fraction (MRI-PDFF), controlled attenuation parameters (CAP), and attenuation coefficients (AC) are capable of steatosis characterization and may be useful as noninvasive alternatives for diagnosing hepatic steatosis.
PURPOSE: This meta-analysis aimed to evaluate the performance of MRI-PDFF, CAP, and AC in grading hepatic steatosis, using histology as the reference standard.
METHODS: We conducted a comprehensive search of the PubMed, Cochrane Library, Embase, and Web of Science databases until June 2024. The quality of eligible studies was assessed. Pooled sensitivity, specificity, and area under receiver operating characteristic (AUC) curves were calculated using a bivariate random-effects model. Meta-regression analysis, subgroup analysis, and Deeks' test were performed to explore heterogeneity and assess publication bias.
RESULTS: This meta-analysis included 38 studies with 5056 patients with metabolic dysfunction-associated steatotic liver disease. The AUC values for grading steatosis ≥S1, ≥S2, and ≥S3 were 0.99, 0.89, and 0.90 for MRI-PDFF, 0.95, 0.84, and 0.77 for CAP, and 0.97, 0.90, and 0.89 for AC, respectively. CAP demonstrated lower accuracy for detecting steatosis grades ≥S2 and ≥S3 compared to MRI-PDFF (0.89 vs. 0.84, p<0.001; 0.90 vs. 0.77, p<0.001) and AC (0.90 vs. 0.84, p<0.001; 0.89 vs. 0.77, p<0.001). Subgroup analyses revealed that MRI-PDFF and CAP exhibited superior diagnostic performance in diagnosing ≥S2 and ≥S3 steatosis among individuals in Asia, with a body mass index ≤30 kg/m2, and age <51 years.
CONCLUSION: A direct comparison with CAP showed greater accuracy for MRI-PDFF and AC in diagnosing moderate and severe steatosis, and similar diagnostic performance for MRI-PDFF and AC. For patients with steatosis, AC should be incorporated into routine ultrasound screening.
引用
- Wu S, Pan J, Song M, et al. Performance of Magnetic Resonance Imaging and Ultrasound for Identifying the Different Degrees of Hepatic Steatosis: A Systematic Review and Meta-analysis. Acad Radiol. 2025. PMID: 40164534. doi:10.1016/j.acra.2025.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。